Abstract
Introduction: rTMS has been proven effective in the treatment of neuropsychiatric conditions, with class A (definite efficacy) evidence for treatment of depression and pain (Lefaucheur et al., 2014). The efficacy in stimulation protocols is, however, quite heterogeneous. Saturation of neuronal firing by HFrTMS without allowing time for recovery may lead to neuronal response failures (NRFs) that compromise the efficacy of stimulation with higher frequencies.Objectives: To examine the efficacy of different rTMS temporal stimulation patterns focusing on a possible upper stimulation limit related to response failures. Protocol patterns were derived from published clinical studies on therapeutic rTMS for depression and pain. They were compared with conduction failures in cell cultures.Methodology: From 57 papers using protocols rated class A for depression and pain (Lefaucheur et al., 2014) we extracted Inter-train interval (ITI), average frequency, total duration and total number of pulses and plotted them against the percent improvement on the outcome scale. Specifically, we compared 10 Hz trains with ITIs of 8 s (protocol A) and 26 s (protocol B) in vitro on cultured cortical neurons.Results: In the in vitro experiments, protocol A with 8-s ITIs resulted in more frequent response failures, while practically no response failures occurred with protocol B (26-s intervals). The HFrTMS protocol analysis exhibited no significant effect of ITIs on protocol efficiency.Discussion: In the neuronal culture, longer ITIs appeared to allow the neuronal response to recover. In the available human dataset on both depression and chronic pain, data concerning shorter ITIs is does not allow a significant conclusion.Significance: NRF may interfere with the efficacy of rTMS stimulation protocols when the average stimulation frequency is too high, proposing ITIs as a variable in rTMS protocol efficacy. Clinical trials are necessary to examine effect of shorter ITIs on the clinical outcome in a controlled setting.
Highlights
RTMS has been proven effective in the treatment of neuropsychiatric conditions, with class A evidence for treatment of depression and pain (Lefaucheur et al, 2014)
The influence of the inter-train interval in Repetitive transcranial magnetic stimulation (rTMS) has been investigated less than that of stimulation frequency (e.g., 1 or 5 Hz) even in the context of basic research, so we examined the premise using the neuronal culture developed by Vardi and coworkers (Vardi et al, 2015)
In the cell culture study, protocol A with the shorter inter-train interval (ITI) was associated with a substantial fraction of response failures, while these were much less frequent in protocol B (Figure 3)
Summary
RTMS has been proven effective in the treatment of neuropsychiatric conditions, with class A (definite efficacy) evidence for treatment of depression and pain (Lefaucheur et al, 2014). The efficacy in stimulation protocols is, quite heterogeneous. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive therapeutic tool for a variety of neuropsychiatric conditions (Lefaucheur et al, 2014). There is class A evidence of the therapeutic utility of rTMS in the treatment of depression and chronic pain (Lefaucheur et al, 2014) which led the FDA to approve the treatment in the USA and Canada for depression (Lefaucheur et al, 2014). As far as stimulation frequency is concerned, there is some consensus on the excitatory effects at higher frequencies and inhibitory effects at lower frequencies (Fitzgerald et al, 2006), further temporal variants play a role
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
